» Articles » PMID: 18664872

Hemophagocytic Syndrome in an Adolescent with Crohn Disease Receiving Azathioprine and Infliximab

Overview
Publisher Wiley
Date 2008 Jul 31
PMID 18664872
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes.

Bramuzzo M, Cananzi M, Alvisi P, Cardile S, Romano C, Aloi M Eur J Pediatr. 2024; 183(12):5411-5418.

PMID: 39404873 DOI: 10.1007/s00431-024-05772-4.


Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.

Zhang H, Zhao S, Cao Z Front Immunol. 2022; 13:1001055.

PMID: 36389673 PMC: 9651941. DOI: 10.3389/fimmu.2022.1001055.


Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease.

Espinheira M, Pinto Pais I, Afonso I, Ferreira J, Trindade E, Amil-Dias J GE Port J Gastroenterol. 2020; 27(5):318-323.

PMID: 32999904 PMC: 7506275. DOI: 10.1159/000507199.


Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review.

Brambilla B, Barbosa A, Scholze C, Riva F, Freitas L, Balbinot R Inflamm Intest Dis. 2020; 5(2):49-58.

PMID: 32596254 PMC: 7315217. DOI: 10.1159/000506514.


A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.

Honkila M, Niinimaki R, Taskinen M, Kuismin O, Kettunen K, Saarela J BMC Infect Dis. 2019; 19(1):404.

PMID: 31077135 PMC: 6509764. DOI: 10.1186/s12879-019-4022-3.